wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 301 - 322 of 322.

Life Sciences - Medicine/Pharmacology
08.09.2016
Bacteria Supply Their Allies With Munitions
Bacteria Supply Their Allies With Munitions
Bacteria fight their competitors with molecular spear guns, the so-called Type VI secretion system. When firing this weapon they also unintentionally hit their own kind.
Business/Economics
07.09.2016
Industry meets science
Industry meets science
A record number of visitors attended this year's Industry Day. Around 550 representatives from industry and business met with scientists for a lively debate on the Hönggerberg.
Physics/Materials Science - Event
06.09.2016
Life Sciences - Physics/Materials Science
06.09.2016
Nanotechnology Supports Treatment of Malignant Melanoma
Nanotechnology Supports Treatment of Malignant Melanoma
Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology. This report researchers from the Swiss Nanoscience Institute, the University of Basel and the University Hospital Basel in first clinical tests with genetic mutations in patients with malignant melanoma.
Physics/Materials Science
06.09.2016
Exploding boules balls
A local festival, a pleasant summer's evening, a friendly game of boules - and suddenly a deafening bang.
Astronomy
05.09.2016
First gravitational waves form after 10 million years
This simulation shows how two galaxies merge over a period of 15 millionen years. The red and the blue dots illustrate the two black holes (image: Astrophysical Journal).
Medicine/Pharmacology
03.09.2016
Novartis’ Ultibro Breezhaler consistently more effective than Seretide * in reducing COPD flare-ups across different patient groups
Novartis' Ultibro Breezhaler consistently more effective than Seretide * in reducing COPD flare-ups across different patient groups Ultibro Breezhaler reduced rate of all COPD exacerbations across different patient sub-groups vs Seretide in new analyses from FLAME study   Analyses show that Ultibro Breezhaler lowered patients' need for rescue medication and had improved benefit-risk profile compared to Seretide, with less evidence of systemic ef
Physics/Materials Science - Microtechnics/Electroengineering
02.09.2016
Michel Calame appointed new head of lab
The Reliability Science and Technology lab is set to focus on the topic of nanoscale transport phenomena and will have a new head, Michel Calame.
Medicine/Pharmacology - Life Sciences
01.09.2016
Phase III study showed Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) helped people with a specific type of lung cancer live significantly longer compared to chemotherapy
Phase III study showed Roche's cancer immunotherapy TECENTRIQ (atezolizumab) helped people with a specific type of lung cancer live significantly longer compared to chemotherapy TECENTRIQ showed significant improvement in overall survival for people regardless of their PD-L1 status Data will be discussed with global health authorities, including the U.S. Food and Drug Administration (FDA) Roche today announced positive results for TECENTRIQ from the Phase III study, OAK.
Agronomy/Food Science - Business/Economics
01.09.2016
Nadja El Benni to head ‘Competitiveness and System Evaluation' Research Division
Nadja El Benni to head ‘Competitiveness and System Evaluation’ Research Division
Bern, 01.09.2016 - Dr. Nadja El Benni was appointed Head of the ‘Competitiveness and System Evaluation' Strategic Research Division by Agroscope Council on 25 August 2016.
Medicine/Pharmacology - Life Sciences
01.09.2016
X-ray View into Cerebellum
X-ray View into Cerebellum
Researchers at the University and University Hospital of Basel succeed in imaging microscopically small structures of the human brain in three dimensions and automatically detecting the number of Purkinje cells in this tissue. They report these results in the journal Scientific Reports. The human being consists of thousand times more cells than the Milky Way has stars.
Medicine/Pharmacology
31.08.2016
Medicine/Pharmacology
31.08.2016
AirFluSal Forspiro showed superiority at 12 months over Seretide Diskus [1] in persistence to treatment
New study shows that rate of patient persistence using Sandoz AirFluSal Forspiro is twice as high as for reference product Seretide Diskus.   Study highlights importance of improving treatment "persistence" over time for long-term respiratory diseases.   Analysis, published in leading medical journal, is largest European Real-World Evidence study ever conducted in asthma and COPD.
Medicine/Pharmacology - Life Sciences
31.08.2016
Antibody Reduces Harmful Brain Amyloid Plaques in Alzheimer's Patients
Antibody Reduces Harmful Brain Amyloid Plaques in Alzheimer’s Patients
Prof. Roger M. Nitsch, MD Institute of Regenerative Medicine University of Zurich Phone +41 44 634 88 71 E-mail Website on clinical trials using Aducanumab PRIME : Phase 1b clinical trial, complete (NCT01677572) EMERGE : Phase III clinical trial, ongoing (NCT02484547) ENGAGE : Phase III clinical trial, ongoing (NCT02477800) Although the causes of Alzheimer's disease are still unknown, it is clear that the disease commences with progre
Environment/Sustainable Development - Earth Sciences
31.08.2016
Freshening of the Southern Ocean
Freshening of the Southern Ocean
Over the past decades, the northward drift of sea ice surrounding Antarctica has strengthened.
Agronomy/Food Science
30.08.2016
Using force to stifle dialogue
Using force to stifle dialogue
In a comment on ETH News, ETH President Lino Guzzella is strongly disapproving the attack on a plant breeding congress. ‘I disapprove of what you say, but I will defend your right to say it.' Although Voltaire himself never uttered these words, they nevertheless capture the spirit of his thinking and thus provide us with a shining example of some of the most important achievements of Enlightenment philosophy: freedom of expression and the supremacy of reason over violence.
Medicine/Pharmacology - Life Sciences
30.08.2016
FDA approves Sandoz Erelzi(TM) to treat multiple inflammatory diseases
Erelzi is the first biosimilar etanercept approved by the FDA, offering expanded access to this important medicine   Erelzi is approved for all indications included in the reference product's label  
Life Sciences - Environment/Sustainable Development
29.08.2016
EUCARPIA Congress at ETH Zurich: Plant Breeding as both Art and Science
EUCARPIA Congress at ETH Zurich: Plant Breeding as both Art and Science
Zurich, 29.08.2016 - A good 400 researchers from the future-oriented field of plant breeding will meet this week at the 20th EUCARPIA General Congress in Zurich, organised by Agroscope and ETH Zurich.
Event - Careers/Employment
29.08.2016
A leader with good instincts
A leader with good instincts
ETH's sixth annual togETHer staff party was held on Friday, 26 th August. It was also a very special occasion for Lorenz Hurni, Professor of Cartography, who was presented with the Golden Tricycle award in recognition of his skill in fostering an optimum balance between work and family life.